Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]

View source ↗

Summary

First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Leukemia
• Low-grade Lymphoma
• Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma
• T-cell Lymphoma

Drugs mentioned

• AMG 319

Snippet

Sponsor: Amgen | Conditions: Cancer, Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED